This study also described that the levels of IL-6 mRNA were most correlated with the degree of inflammation in the intestinal mucosa and this was expressed only in the inflamed mucosa—suggesting that IL-6 is a possible target in the IBD treatment. The gene discussed is IL6; the disease is inflammatory bowel disease.